Medical devices, healthcare technology and the business of care
510(k) clearance · K254135

LipoSurg ARTIST

NOUVAG AG · Decision date Sep 5, 2026

MEDTECHLEDGER EXPLANATIONK254135

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for LipoSurg ARTIST, a suction lipoplasty removal system submitted by NOUVAG AG of Goldach, Switzerland, under 510(k) number K254135. The decision date is 09/05/2026; the application was received 12/22/2025 and handled as a traditional 510(k) reviewed by FDA rather than a third party. SESE means the device was cleared as substantially equivalent to a predicate, not approved through the PMA pathway.

The record lists regulation number 878.5040, product code QPB, and the General & Plastic Surgery specialty and review panel. The submission was not a combination product, and no predetermined change control plan was authorized. The public record does not include the predicate device, the specific components or changes described in the submission, or the indications for use; those details would sit in the underlying FDA documents rather than this summary page.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Sep 5, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K254135
Regulatory pathway
510(k) premarket notification
Applicant
NOUVAG AG
Product code
QPB
Decision code
SESE
Decision date
Sep 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Suction, Lipoplasty For Removal.

Applicant
NOUVAG AG
Product code
QPB
FDA device class
2

FDA decision timeline

  1. K254135 received

    Application receipt date recorded by FDA.

  2. K254135 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

NOUVAG AG

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Sankt Gallen

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records